Generate a tailored SOP for Dr. Vladimir Katanaev. Improve your application with a focused, well-structured draft.
Vladimir Katanaev is a full professor at the University of Geneva's Centre for Translational Research in Oncohaematology. His fundamental research focuses on oncogenic signaling pathways, particularly the Wnt/Frizzled pathway, which is crucial for organismal development and is often misactivated in various cancers. Katanaev's laboratory has been active in identifying novel components of the Wnt pathway that could serve as potential drug targets for cancer therapies. He integrates fundamental and translational research, employing diverse approaches to understand GPCR signaling and its implications in pediatric encephalopathies. Having studied biology and biochemistry at Krasnoyarsk State University and Moscow State University, he completed his doctorate at the University of Fribourg in 2000. Katanaev has held prestigious positions, including a post-doctorate at Columbia University and leading a research group at the University of Konstanz before joining the University of Lausanne as an associate professor. He has also contributed significantly to the field of anti-cancer drug discovery through his innovative research and collaboration.
University of Geneva • Geneva, Switzerland
Leading research on oncogenic signaling pathways and drug discovery.
University of Lausanne • Lausanne, Switzerland
Focused on intracellular signaling and its implications in cancer.
University of Konstanz • Konstanz, Germany
Conducted research on intracellular signaling pathways in developmental biology.
Columbia University • New York, USA
Researched Wnt signaling pathways using Drosophila models.
Includes Department of Management, Finance, Economics, and Statistics programs. GMAT is strongly encouraged but not mandatory for most GSEM masters.